Abstract: Erythrodermic psoriasis is a rare but severe type of psoriasis that may be triggered by human immunodeficiency virus infection. We describe the case of a 65-year-old male patient with chronic psoriasis who presents an exacerbation of his condition over a period of two weeks. Because of the severity of his case and subsequent need for systemic therapy, human immunodeficiency virus enzyme immunoassay was performed and tested positive. He thus began antiretroviral therapy combined with acitretin, showing good clinical response after 8 weeks of treatment. There is little evidence regarding the management of erythrodermic psoriasis associated with HIV infection, so antiretroviral therapy and systemic retinoid remain as the first-line treatment.
INTRODUCTION
Psoriasis is a chronic inflammatory skin disease and is prevalent in 2-3% of the world population. 1 It has several phenotypes of which erythrodermic psoriasis is an uncommon and severe variant. It is characterized by erythema involving more than 75% or 90% of the body surface area, according to different authors. 2, 3 We present a case of erythrodermic psoriasis associated with a recently detected human immunodeficiency virus (HIV) infection.
CASE REPORT
A 65-year-old male patient with chronic psoriasis since he was 14 years old attended regular checkups and had irregular topical corticosteroid therapy. Over the course of two weeks, erythematous scaly plaques increased both in extension and depth. The patient reported severe skin pain (10/10 on the visual analogue scale), fever up to 39.7ºC, and weight loss of approximately 3kg in two weeks. He was not on any new medication.
Physical examination revealed purple-erythematous plaques with fine scaling on the scalp, trunk, and upper and lower extremities, compromising 90% of his body surface area ( Figure 1 ).
There were no pustules, and the mucosa was not affected. 
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FIgure 1: Patient with erythrodermic psoriasis and HIV infection of recent diagnosis. Purplee r y t h e m a t o u s plaques with fine scaling extend from trunk to upper and lower extremities
DISCUSSION
Erythrodermic psoriasis is a rare type of psoriasis, present in 1% to 2.25% of all psoriatic patients, 2 and constitutes the main cause of erythroderma, comprising 25% of the cases. 2 Erythrodermic psoriasis mostly presents in adult males, although it has been reported in different age groups, including congenital cases. 3 Even though erythrodermic psoriasis may be the first manifestation of psoriasis, it usually manifests in patients with longstanding chronic psoriasis, generally 11 to 18 years after diagnosis. HIV-associated psoriasis without erythroderma. 6 However, one must
